Cortisol in Peripheral Blood Predicts the Severity and Prognosis in Patients with Liver Failure at 90 Days

Jian Zhang,Junfeng Li,Mei Ding,Yu Chen,Zhongping Duan

DOI: https://doi.org/10.2147/RMHP.S327440

2021-10-17

Risk Management and Healthcare Policy

Abstract:Jian Zhang, 1 Junfeng Li, 2 Mei Ding, 1 Yu Chen, 1 Zhongping Duan 1 1 Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China; 2 Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, 730000, People's Republic of China Correspondence: Zhongping Duan Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, No. 8, You An Men Outer Street, Fengtai District, Beijing, 100069, People's Republic of China Tel +86-13466675122 Email Objective: To investigate the cortisol level in peripheral blood in evaluating the severity and prognosis of patients with liver failure. Methods: A total of 211 inpatients with liver failure were enrolled in Beijing You 'an Hospital affiliated with Capital Medical University, from September 2018 to January 2020. They were divided into three groups according to the severity of liver failure: early-stage liver failure, medium-stage liver failure and end-stage liver failure. In all patients, peripheral venous blood was gathered to detect the level of peripheral cortisol and related biochemical indexes. Logistic regression was used to screen the risk factors affecting the prognosis of patients at 90 days. A receiver operating curve (ROC) was used to reflect the value of cortisol on the prognosis of patients at 90 days. A model for end-stage liver disease (MELD) was accessed. Results: Among these 211 patients with liver failure, aged from 19 to 70 years, the average level of cortisol was 351.26 ± 129.78 nmol/L for 101 cases with early-stage liver failure, 281.05 ± 81.31 nmol/L for 58 cases with medium-stage liver failure, and 189.21 ± 89.27 nmol/L for 52 cases with end-stage liver failure ( P < 0.05). The level of cortisol in the survival group and the non-survival group was 339.26 ± 121.19 nmol/L and 192.71 ± 67.23 nmol/L, respectively ( P < 0.05). The results of logistics regression analysis showed that the odds ratio (OR) and 95% confidence intervals (CI) of cortisol were 1.025 and 1.013– 1.038 nmol/L ( P < 0.05). MELD results showed that patients with higher MELD scores had lower cortisol content. Conclusion: The level of cortisol is correlated with the severity of liver failure and decreases with the aggravation of liver failure, suggesting that the level of cortisol could be used as one of the indicators to evaluate the prognosis in patients with liver failure at 90 days. Keywords: liver, liver failure, prognosis, cortisol Liver failure, which remains a worldwide health problem, is a complex syndrome caused by a variety of factors, leading to severe disorder or decompensation of synthesis, detoxification, metabolism and biotransformation functions, with jaundice, coagulation dysfunction, hepatorenal syndrome, hepatic encephalopathy, and ascites as the main manifestations of a group of clinical syndromes. 1–4 Many reasons cause liver failure. Hepatitis B virus (HBV) is the leading cause of liver failure in China, and the mortality rate ranges from 50%–80%. 5–7 It has been reported that patients with liver failure have a very high mortality rate at 90 days of illness. 8–10 At present, there is no effective treatment except liver transplantation. Liver transplantation could significantly reduce mortality in patients, but its clinical application is limited due to the lack of liver sources and its high cost. 11–13 Therefore, an early and accurate assessment of patients with liver failure could provide the appropriate treatment for improving the prognosis of patients. Currently, the commonly used methods for evaluating the severity and prognosis of patients with liver failure are mostly based on the functions of multiple organs themselves. 14–17 But this method has limitations in terms of accuracy and convenience of application. Hormones play an important role in body metabolism and organ function regulation. Previous studies have suggested that glucocorticoids may be helpful in the treatment of severe liver failure, which is often associated with adrenal failure. 18 Cortisol is an endogenous glucocorticoid secreted by the adrenal cortex, and it is an important cholesterol derivative for maintaining life homeostasis. 19 The concentration of corticosteroid-binding globulin decreased acutely, and its binding affinity with cortisol decreased. 20 This suggests that baseline cortisol levels may serve as a prognostic indicator and may be used to determine the severity of liver failure. In this study, a prospective -Abstract Truncated-

health care sciences & services,health policy & services